Cargando…
P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428938/ http://dx.doi.org/10.1097/01.HS9.0000969080.96146.ca |
_version_ | 1785090590575165440 |
---|---|
author | Nedumannil, Rithin Batterham, Emily Wei, Andrew Bajel, Ashish |
author_facet | Nedumannil, Rithin Batterham, Emily Wei, Andrew Bajel, Ashish |
author_sort | Nedumannil, Rithin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104289382023-08-17 P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA Nedumannil, Rithin Batterham, Emily Wei, Andrew Bajel, Ashish Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428938/ http://dx.doi.org/10.1097/01.HS9.0000969080.96146.ca Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Nedumannil, Rithin Batterham, Emily Wei, Andrew Bajel, Ashish P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA |
title | P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA |
title_full | P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA |
title_fullStr | P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA |
title_full_unstemmed | P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA |
title_short | P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA |
title_sort | p543: consecutive day dosing of high-dose cytarabine consolidation over 3 days is feasible in older patients with acute myeloid leukemia |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428938/ http://dx.doi.org/10.1097/01.HS9.0000969080.96146.ca |
work_keys_str_mv | AT nedumannilrithin p543consecutivedaydosingofhighdosecytarabineconsolidationover3daysisfeasibleinolderpatientswithacutemyeloidleukemia AT batterhamemily p543consecutivedaydosingofhighdosecytarabineconsolidationover3daysisfeasibleinolderpatientswithacutemyeloidleukemia AT weiandrew p543consecutivedaydosingofhighdosecytarabineconsolidationover3daysisfeasibleinolderpatientswithacutemyeloidleukemia AT bajelashish p543consecutivedaydosingofhighdosecytarabineconsolidationover3daysisfeasibleinolderpatientswithacutemyeloidleukemia |